Evidence map›Paper›PMID 30897821›Full record

ArticleCells2019

Inhibition of Mitochondrial Complex Function-The Hepatotoxicity Mechanism of Emodin Based on Quantitative Proteomic Analyses.

Longfei Lin, Yuling Liu, Sai Fu, Changhai Qu, Hui Li, Jian Ni

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Hepatotoxic metabolites inFrontiers in pharmacology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Longfei LinInstitute Chinese materia medica china academy of Chinese medical sciences, Beijing 100700, China. linlongfei0417@126.com.
Yuling LiuInstitute Chinese materia medica china academy of Chinese medical sciences, Beijing 100700, China. ylliu@icmm.ac.cn.
Sai FuInstitute Chinese materia medica china academy of Chinese medical sciences, Beijing 100700, China. fusai920412@126.com.
Changhai QuSchool of Chinese material medica, Beijing University of Chinese Medicine, Beijing 100102, China. quchanghai@bucm.edu.cn.
Hui LiInstitute Chinese materia medica china academy of Chinese medical sciences, Beijing 100700, China. lihuizys@126.com.
Jian NiSchool of Chinese material medica, Beijing University of Chinese Medicine, Beijing 100102, China. njtcm@263.net.
China Academy of Chinese Medical Sciences · CNBeijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emodin is the main component of traditional Chinese medicines including rhubarb,

Indexed as

ApoptosisCell CountCell LineCell ProliferationElectron TransportEmodinGene OntologyHumansLiverMembrane Potential, MitochondrialMitochondriaModels, BiologicalOxidative PhosphorylationProteomeProteomicsSignal TransductionEmodinProteomecomplexemodinhepatotoxicitymitochondrialproteomic

Identifiers

PMID30897821
PMCPMC6468815
OpenAlexW2922846941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.